MIA's Ana Florence interviews recovery advocate Ro Speight about her journey from receiving Peer Support to working as a facilitator in Peer Partnered Open Dialogue.
A new study by Peter Groot and Jim van Os investigated whether tapering strips can help people stop using antidepressants.
An article in JAMA Psychiatry advises very slow tapering for best results when discontinuing antipsychotic drugs.
A new study has found a strong association between antipsychotic drugs and higher rates of severe cases of COVID-19.
A new review of strategies to support both patients and practitioners through the process of discontinuing antidepressants.
New strategies for tapering psychiatric drugs achieved by acknowledging withdrawal symptoms and valuing service-users’ first-hand knowledge.
MIA's Tim Beck interviews psychologist Ian Tucker about the relationships between digital technologies, emotion, and mental health.
Researchers studied whether antipsychotics could prevent transition to full psychosis and found that the drugs worsened outcomes.
A new study published in JAMA Psychiatry connects antipsychotics with damage to the brain in multiple areas.
National data on rates of youth antidepressant prescription, suicide, and self-harm in Australia sparks public health debate about drug safety.
Study finds an apparent connection between SSRIs, the most commonly prescribed type of antidepressant, and increased risk of violent crime.
Once an appropriate statistical method was used, the study findings were “no longer valid,” according to the editors of JAMA and JAMA Psychiatry.
Researchers find that most psychiatric drugs cause severe withdrawal despite attempt s to gradually decrease the dosage.
“This is remarkable for drugs that are used to treat depressive symptoms,” write the researchers.
Researchers suggest that because most antidepressant “success” is due to the placebo effect, they may never find a way to predict outcomes.
MIA’s Ayurdhi Dhar interviews Sunil Bhatia about decolonizing psychology, confronting the field’s racist past, colonial foundations, and neoliberal present.
Neuropsychological assessments reveal the cognitive, occupational, and social impact of polypharmacy in psychiatry.
A new review of antipsychotic trials conducted over the last 24 years finds that the placebo response rate is steadily increasing, and drug response is decreasing.
New study finds that Medicaid enrolled youth were 14 times more likely to be on an antidepressant in 2014 than in 1987.
Researchers at Johns Hopkins test paroxetine on developing brain cells and discover numerous neurotoxic effects.
New research counters the long-held assumption that a longer duration of untreated psychosis is associated with worse outcomes.
MIA’s Ayurdhi Dhar interviews Ian Parker about critical psychology, discourse and political action, and whether psychology has anything left to offer.
Recent research implicates benzodiazepines as being involved in a high rate of emergency department visits in the US.
Researchers confirm that the suicide warning for antidepressants is justified by the evidence and that claims that the warning is harmful lack support.
A new survey exploring antipsychotic user experience finds that more than half of the participants report only negative experiences.